COSCIENS Biopharma Inc. (CSCIF) Net income 2016–2025
COSCIENS Biopharma Inc. (CSCIF) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$10.4MFY2025 · since FY2016: -$25.0M → -$10.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$10.4M | +32.3% |
| FY2024 | -$15.3M | -339.3% |
| FY2023 | -$3.5M | -201.1% |
| FY2022 | $3.4M | +141.2% |
| FY2021 | -$8.4M | -63.5% |
| FY2020 | -$5.1M | +15.3% |
| FY2019 | -$6.0M | -244.3% |
| FY2018 | $4.2M | +124.9% |
| FY2017 | -$16.8M | +32.7% |
| FY2016 | -$25.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice